Literature DB >> 7859290

OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins.

M Strubin1, J W Newell, P Matthias.   

Abstract

Recent biochemical and genetic studies indicate that in addition to the octamer-binding proteins Oct-1 and Oct-2, other B cell components are required for lymphoid-restricted, octamer site-mediated immunoglobulin gene promoter activity. Using a genetic screen in yeast, we have isolated B cell-derived cDNAs encoding Oct-binding factor 1 (OBF-1), a novel protein that specifically associates with Oct-1 and Oct-2. Biochemical studies demonstrate that OBF-1 has no intrinsic DNA-binding activity and recognizes the POU domains of Oct-1 and Oct-2, but not those of Oct-4 and Oct-6. The OBF-1 mRNA is expressed in a highly cell-specific manner, being most abundant in B cells and essentially absent in most of the other cells or tissues tested. Furthermore, expression of OBF-1 in HeLa cells selectively stimulates the activity of a natural immunoglobulin promoter in an octamer site-dependent manner. Thus, OBF-1 has all the properties expected for a B cell-specific transcriptional coactivator protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7859290     DOI: 10.1016/0092-8674(95)90500-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  131 in total

1.  Purification of transcription cofactor complex CRSP.

Authors:  S Ryu; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Zufferey; V Steimle; W Reith
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

3.  Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex: specific recognition of a protein-DNA interface.

Authors:  D Chasman; K Cepek; P A Sharp; C O Pabo
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

4.  Identification of an octamer element required for in vivo expression of the TIE1 gene in endothelial cells.

Authors:  S C Boutet; T Quertermous; B M Fadel
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

5.  The RING finger protein Siah-1 regulates the level of the transcriptional coactivator OBF-1.

Authors:  R Tiedt; B A Bartholdy; G Matthias; J W Newell; P Matthias
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

6.  CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.

Authors:  S B Hake; K Masternak; C Kammerbauer; C Janzen; W Reith; V Steimle
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

7.  Activator recruitment by the general transcription machinery: X-ray structural analysis of the Oct-1 POU domain/human U1 octamer/SNAP190 peptide ternary complex.

Authors:  Stacy Hovde; Craig S Hinkley; Katie Strong; Aimee Brooks; Liping Gu; R William Henry; James Geiger
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

8.  The VP16 paradox: herpes simplex virus VP16 contains a long-range activation domain but within the natural multiprotein complex activates only from promoter-proximal positions.

Authors:  M Hagmann; O Georgiev; W Schaffner
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  Herpes simplex virus infections are arrested in Oct-1-deficient cells.

Authors:  Mauricio L Nogueira; Victoria E H Wang; Dean Tantin; Phillip A Sharp; Thomas M Kristie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

10.  B cell development and immunoglobulin transcription in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Dean Tantin; Jianzhu Chen; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.